Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Infectious Diseases

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/605561PMID 19725787PMCID PMC2741541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-induced liver injury.

  2010cited by this paper
• Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection.

  2009cited by this paper
• Surveillance for acute viral hepatitis - United States, 2007.

  2009cited by this paper
• Acute hepatitis C virus infection.

  2008cited by this paper
• A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

  2007cited by this paper
• Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis

  2007cited by this paper
• Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users.

  2007cited by this paper
• The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy

  2007cited by this paper
• Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.

  2007cited by this paper
• Surveillance for acute viral hepatitis--United States, 2005.

  2007cited by this paper
• Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.

  2006cited by this paper
• Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T‐cell responses

  2006cited by this paper
• Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

  2006influential reference
• Duration of peginterferon therapy in acute hepatitis C: A randomized trial

  2006cited by this paper
• Early monotherapy with pegylated interferon alpha‐2b for acute hepatitis C infection: The HEP‐NET acute‐HCV‐II study

  2006cited by this paper
• Outcomes and treatment of acute hepatitis C virus infection in a United States population.

  2006cited by this paper
• Self-Reported Hepatitis C Virus Antibody Status and Risk Behavior in Young Injectors

  2006cited by this paper
• Acute hepatitis C virus infection in incarcerated injection drug users.

  2006cited by this paper
• Adaptive immune responses in acute and chronic hepatitis C virus infection

  2005cited by this paper
• Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

  2005cited by this paper
• Immunology of hepatitis B virus and hepatitis C virus infection

  2005cited by this paper
• Acute hepatitis C virus infection.

  2005cited by this paper
• Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance.

  2005cited by this paper
• Drug-induced liver injury.

  2004cited by this paper
• Diagnosis, management, and treatment of hepatitis C

  2004cited by this paper
• Natural course of acute hepatitis C: a long-term prospective study.

  2003cited by this paper
• Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

  2003cited by this paper
• Management of hepatitis C.

  2003cited by this paper
• Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

  2003cited by this paper
• Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

  2002cited by this paper
• Fluctuation of serum HCV‐RNA levels in untreated blood donors with chronic hepatitis C virus infection

  2002cited by this paper
• Therapy of acute hepatitis C

  2002cited by this paper
• Treatment of acute hepatitis C with interferon alfa-2b.

  2001cited by this paper
• Acute hepatitis C

  2001cited by this paper
• Relation Between HIV‐1 and Hepatitis C Viral Load in Patients With Hemophilia

  2001cited by this paper
• Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study

  2000cited by this paper
• Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

  1999cited by this paper
• The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C

  1998cited by this paper
• Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification

  1998cited by this paper
• Fluctations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection

  1996cited by this paper
• Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection.

  1996cited by this paper
• [Therapy of acute hepatitis].

  1968cited by this paper
• SERUM ENZYME LEVELS IN THE DIAGNOSIS OF HEPATIC DISEASE.

  1963cited by this paper

• Detection of anti-HCV antibodies in the clinical classification and epidemiological surveillance of HCV infection

  2025influential citation
• Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

  2025cites this paper
• HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.

  2023cites this paper
• Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors

  2023cites this paper
• Acute Hepatitis C After Penile Stem Cell Injection

  2022influential citation
• RAS MICROBIOLOGY AND INFECTIOUS DISEASES Review Article: Moving ahead in HCV diagnostics: Need for the introduction of HCV core antigen assay in low and middle-income countries

  2021cites this paper
• The nature and prognosis of renal diseases in chronic hepatitis-C-infected diabetic Egyptian patients: The role of renal biopsy.

  2021cites this paper
• Management of Acute HCV Infection

  2021cites this paper
• Moving ahead in HCV diagnostics: Need for the introduction of HCV core antigen assay in low and middle-income countries

  2021cites this paper
• Management of Acute HCV Infection

  2021cites this paper
• Management of Acute HCV Infection

  2021cites this paper
• Management of Acute HCV Infection

  2021cites this paper
• Management of Acute HCV Infection

  2021cites this paper
• A case of acute exacerbation of chronic hepatitis C during the course of adrenal Cushing's syndrome

  2021cites this paper
• aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C

  2021cites this paper
• Management of Acute HCV Infection

  2021cites this paper
• Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature.

  2021cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• CD4+ T cell restoration and control of hepatitis C virus replication after childbirth.

  2020cites this paper
• T-Cell Immunity against the Hepatitis C Virus: A Persistent Research Priority in an Era of Highly Effective Therapy.

  2020cites this paper
• Dried blood spot self-sampling at home is a feasible technique for hepatitis C RNA detection

  2020cites this paper
• Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study

  2020cites this paper
• The clinical impact of hepatitis C virus infection in Egyptian multiple myeloma patients

  2020cites this paper
• Clinical Influence of Hepatitis C Virus Eradication by Direct-acting Antivirals on Lipid Levels and “Ningen Dock” Health Check-up Categories in Patients with Chronic Hepatitis C Virus Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• Management of Acute HCV Infection

  2020cites this paper
• HCV-RNA is commonly detectable in rectal and nasal fluids of patients with high viremia.

  2020cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Elevated serum levels of adiponectin and interlukin-28 B after IFN / RIB therapy in hepatitis C virus-infected patients

  2019cites this paper
• Oncologic Implications of Chronic Hepatitis C Virus Infection.

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biological agent: A nine-year multicenter cohort study.

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Evaluation of the Aptima HCV Quant Dx Assay Using Serum and Dried Blood Spots

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Management of Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Active Hepatitis C Leading to Refractory Thrombotic Thrombocytopenic Purpura – A Dubious Association and The Challenges Faced in Management.

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Diagnosis of Acute HCV Recommended Testing for Diagnosing Acute HCV Infection

  2019cites this paper
• Unique Populations

  2018cites this paper
• Management of chronic viral hepatitis in the hematological patient

  2018influential citation
• Management of Unique Populations with HCV Infection

  2018cites this paper
• Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients

  2018cites this paper
• Management of acute HCV infection in the era of direct-acting antiviral therapy

  2018cites this paper
• Hepatitis C virus genotyping of organ donor samples to aid in transplantation of HCV‐positive organs

  2018cites this paper
• Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct‐acting antivirals

  2018cites this paper
• Inhibition of Hepatitis C Virus Replication Induced by Chemotherapy: A Prospective Observational Study.

  2018cites this paper
• Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection

  2018cites this paper
• HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

  2018cites this paper